Bris­tol My­ers gets its first GI drug ap­proval, and it comes from a long­time Cel­gene MS pro­gram

A for­mer long­time Cel­gene pro­gram that saw a bumpy road to ap­proval has picked up a new OK, with its new own­ers at Bris­tol My­ers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.